Esophageal cancer is a serious and globally prevalent malignancy associated with high morbidity and mortality rates. The palliative management of dysphagia, a common and debilitating symptom in advanced esophageal cancer, often includes endoscopic stenting. This chapter explores the role of esophageal stenting as a therapeutic intervention, primarily for symptom relief in patients with unresectable tumors or poor prognosis. The efficacy of stents in reducing dysphagia, techniques for their placement, and the selection criteria for patients are discussed, with a focus on optimizing outcomes and minimizing complications. Complications range from mild symptoms, such as pain and reflux, to severe adverse events like stent migration and perforation. Patient selection requires a multidisciplinary approach. Esophageal stenting is not curative, it remains a critical component of palliative care, enhancing the quality of life for esophageal cancer patients.